Image

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-small Cell Lung Cancers

Study on the Effectiveness of Investigational Medication After Surgery and Chemotherapy for Lung Cancer (Non-Small Cell)

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates how well an investigational medication works after surgery and chemotherapy in treating patients with stage IB-IIIA non-small cell lung cancer. Non-small cell lung cancer is a type of lung cancer that includes several subtypes, and it is categorized based on tumor size and spread. The study aims to evaluate if adding this medication can improve survival rates compared to standard observation after surgery and chemotherapy.

Participants in this study will undergo procedures that include regular imaging tests to monitor their condition. Imaging tests like chest CT scans help doctors see inside the body to check for signs of cancer. Participants will be randomly assigned to receive either the investigational medication or to be in the observation arm, where they will not receive the medication.

  • Who can participate: Adults 18 years and older who have had surgery for stage IB (4 cm or larger), II, or IIIA non-small cell lung cancer with negative surgical margins can participate. They must have a good performance status and be registered in a specific screening trial.
  • Study details: Participants will either receive the investigational medication or be observed without it. The investigational medication is given after surgery and chemotherapy to see if it improves survival.
Print
Study details
    Non-Small Cell Lung Carcinoma
    non small cell lung carcinoma
    non-small cell lung cancer
    non small cell lung carcinoma
    non-small cell
    non small cell
    lung cancer
    lung carcinoma
    lung
    lungs
    cancer
    oncology

TX7372

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.